|
Merck Bets $15 Million on Ambrx’s ‘Smart Bomb’ Antibodies
Merck is making its first move into one of the hotter corners of biotech, by forming a partnership to make “smart bomb” antibody drugs with San Diego-based Ambrx.
Xconomy |
|
Merck Bets $15 Million on Ambrx’s ‘Smart Bomb’ Antibodies
Merck is making its first move into one of the hotter corners of biotech, by forming a partnership to make “smart bomb” antibody drugs with San Diego-based Ambrx.
Xconomy |
Register Now
Archives